Published in Psychopharmacology (Berl) on November 14, 2008
Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol Neurodegener (2010) 1.68
Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol (2011) 1.37
Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis (2012) 1.31
Cellular and molecular actions of Methylene Blue in the nervous system. Med Res Rev (2011) 1.22
Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS One (2011) 1.03
Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats. Psychopharmacology (Berl) (2011) 1.02
Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. Learn Mem (2010) 0.88
Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice. Psychopharmacology (Berl) (2014) 0.87
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. Acta Neuropathol Commun (2015) 0.87
WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res (2010) 0.82
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions. Front Pharmacol (2015) 0.82
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease. Biomed Res Int (2016) 0.81
Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models. Behav Pharmacol (2015) 0.81
Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials. Biomed Res Int (2014) 0.81
Protective effects of mangosteen extract on H2O2-induced cytotoxicity in SK-N-SH cells and scopolamine-induced memory impairment in mice. PLoS One (2013) 0.81
Evaluation of the effect of Cyperus rotundus L. in scopolamine-induced learning deficit in mice. Adv Biomed Res (2014) 0.80
5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice. Psychopharmacology (Berl) (2012) 0.79
Differential metformin dose-dependent effects on cognition in rats: role of Akt. Psychopharmacology (Berl) (2016) 0.79
Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice. J Biol Chem (2014) 0.76
An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine. Br J Clin Pharmacol (2017) 0.75
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10
The cholinergic hypothesis of geriatric memory dysfunction. Science (1982) 6.84
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA (2004) 6.74
Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev (2006) 5.81
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ (2005) 3.83
Human memory and the cholinergic system. A relationship to aging? Arch Neurol (1974) 2.24
The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther (2003) 2.13
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A (1996) 2.11
Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci (2001) 1.88
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport (2001) 1.63
Brain cytochrome oxidase in Alzheimer's disease. J Neurochem (1992) 1.48
Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol (2003) 1.43
Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox Signal (2007) 1.35
Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol Biochem Behav (2004) 1.31
Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav (2003) 1.23
Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog Neurobiol (1999) 1.23
Extinction memory improvement by the metabolic enhancer methylene blue. Learn Mem (2004) 1.14
Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol (1999) 1.14
Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab (1983) 1.13
Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci Lett (2002) 1.12
Changes in acetylcholine extracellular levels during cognitive processes. Learn Mem (2004) 1.09
Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett (2004) 1.09
Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol (1991) 1.07
Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem (1976) 1.06
Structure and activation of muscarinic acetylcholine receptors. Biochem Soc Trans (2003) 1.05
Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval. Pharmacol Biochem Behav (2006) 1.04
Ascorbic Acid: a promising memory-enhancer in mice. J Pharmacol Sci (2003) 1.04
The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacol Biochem Behav (2007) 1.01
Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol (2007) 0.98
Reversible hippocampal inactivation partially dissociates how and where to search in the water maze. Behav Neurosci (2004) 0.98
Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology (Berl) (2005) 0.95
Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study. J Clin Psychopharmacol (2005) 0.93
An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Eur J Pharmacol (1996) 0.92
The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice. Neurobiol Learn Mem (2006) 0.92
Anxiety-related behavior and densities of glutamate, GABAA, acetylcholine and serotonin receptors in the amygdala of seven inbred mouse strains. Behav Brain Res (2003) 0.92
Inhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol Cell Biochem (2003) 0.92
The Morris water-escape task in mice: strain differences and effects of intra-maze contrast and brightness. Physiol Behav (1996) 0.91
Gomisin A improves scopolamine-induced memory impairment in mice. Eur J Pharmacol (2006) 0.90
Dissociation of cholinergic function in spatial and procedural learning in rats. Neuroscience (2007) 0.90
Neurotoxic effects of two different pyrethroids, bioallethrin and deltamethrin, on immature and adult mice: changes in behavioral and muscarinic receptor variables. Toxicol Appl Pharmacol (1991) 0.88
Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease. Psychopharmacology (Berl) (2007) 0.88
Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology (Berl) (1987) 0.87
Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behav Brain Res (2007) 0.87
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology (Berl) (2006) 0.87
Neuropsychological test performance in healthy volunteers before and after donepezil administration. J Psychopharmacol (2004) 0.85
Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats. Brain Res (2007) 0.85
The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice. Neurobiol Learn Mem (1995) 0.84
Effects of early spatial training on water maze performance: a longitudinal study in mice. Exp Gerontol (2002) 0.84
Glucose attenuation of memory impairments. Behav Neurosci (2000) 0.84
Spatial processing and emotionality in aged NMRI mice: a multivariate analysis. Physiol Behav (1993) 0.83
Acteoside of Callicarpa dichotoma attenuates scopolamine-induced memory impairments. Biol Pharm Bull (2006) 0.83
Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease. Int J Dev Neurosci (2001) 0.83
Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients. Brain Res (1997) 0.82
Intravenous scopolamine is potently self-administered in drug-naive mice. Neuropsychopharmacology (2000) 0.82
Effects of selegiline alone or with donepezil on memory impairment in rats. Eur J Pharmacol (2005) 0.81
Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacol Biochem Behav (1996) 0.81
Previous training in the water maze: differential effects in NMRI and C57BL mice. Physiol Behav (1999) 0.81
Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology (2008) 0.81
Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Dement Geriatr Cogn Disord (2007) 0.81
Investigation into sex-related differences in locomotor activity, place learning and passive avoidance responding in NMRI mice. Physiol Behav (1988) 0.81
Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Res (1999) 0.80
Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147. Acta Pharmacol Sin (2002) 0.79
7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology (1996) 0.79
The interaction between methylene blue and the cholinergic system. Br J Pharmacol (1997) 0.79
The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. J Psychopharmacol (2006) 0.79
The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats. Life Sci (2005) 0.78
Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice. Brain Res (2001) 0.78
Visual acuity in the water maze: sensitivity to muscarinic receptor blockade in rats and mice. Behav Brain Res (2004) 0.78
Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose. Behav Neural Biol (1992) 0.78
Simplifying environmental cues in a Morris-type water maze improves place learning in old NMRI mice. Behav Neural Biol (1991) 0.78
Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. Physiol Behav (1990) 0.77
Behavioural, biochemical and histological effects of AF64A following injection into the third ventricle of the mouse. Behav Brain Res (1992) 0.77
Cholinergic agents and delay-dependent performance in the rat. Pharmacol Biochem Behav (1994) 0.77
The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats. Psychopharmacology (Berl) (1999) 0.77
Glucose enhancement of scopolamine-induced increase of hippocampal high-affinity choline uptake in mice: relation to plasma glucose levels. Brain Res (1995) 0.76
Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficits. Pharmacol Biochem Behav (1991) 0.75
A performance-dependent adjustment of the retention interval in a delayed non-matching-to-position paradigm differentiates effects of amnestic drugs in rats. Eur J Pharmacol (2000) 0.75
Changes in myocardial mitochondrial electron transport activity in rats administered with acetylcholinesterase inhibitor. Biochem Biophys Res Commun (1989) 0.75
Involvement of striatal cholinergic receptors in reaction time and fixed-interval responding in rats. Brain Res Bull (1998) 0.75
N-tert-butyl-alpha-phenylnitrone, a free radical scavenger with anticholinesterase activity does not improve the cognitive performance of scopolamine-challenged rats. Int J Dev Neurosci (2001) 0.75
Effect of a M1 allosteric modulator on scopolamine-induced amnesia. Med Chem (2007) 0.75
Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci (2008) 2.04
Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nat Neurosci (2011) 1.78
In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau. Exp Neurol (2011) 1.45
The cholinergic system, EEG and sleep. Behav Brain Res (2011) 1.30
Foreground contextual fear memory consolidation requires two independent phases of hippocampal ERK/CREB activation. Learn Mem (2006) 1.18
Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain (2012) 1.14
The cholinergic system and hippocampal plasticity. Behav Brain Res (2010) 1.11
Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain Res (2011) 1.10
Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS One (2011) 1.03
The cholinergic system and spatial learning. Behav Brain Res (2010) 1.03
Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats. Neuropharmacology (2004) 1.01
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl) (2011) 1.00
EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. J Alzheimers Dis (2010) 1.00
Memantine acts as a cholinergic stimulant in the mouse hippocampus. J Alzheimers Dis (2007) 0.97
Inference of Granger causal time-dependent influences in noisy multivariate time series. J Neurosci Methods (2011) 0.93
Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berl) (2007) 0.92
Syntheses and energy transfer in multiporphyrinic arrays self-assembled with hydrogen-bonding recognition groups and comparison with covalent steroidal models. Chemistry (2007) 0.91
Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints. Acta Neuropathol (2008) 0.89
Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure. Hippocampus (2010) 0.89
Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. Learn Mem (2010) 0.88
Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. Ann N Y Acad Sci (2005) 0.87
The seed extract of Cassia obtusifolia offers neuroprotection to mouse hippocampal cultures. J Pharmacol Sci (2008) 0.87
Cannabinoids alter spontaneous firing, bursting, and cell synchrony of hippocampal principal cells. Hippocampus (2011) 0.86
The septo-hippocampal system, learning and recovery of function. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.85
Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases. J Neurochem (2007) 0.84
Calcyclin binding protein and Siah-1 interacting protein in Alzheimer's disease pathology: neuronal localization and possible function. Neurobiol Aging (2012) 0.83
Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus. Neuropharmacology (2011) 0.83
Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine. Neurosci Lett (2005) 0.82
Mapping changes in mouse brain metabolism with PET/CT. J Nucl Med (2013) 0.82
WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res (2010) 0.82
A comparative study of the actions of alkylpyridinium salts from a marine sponge and related synthetic compounds in rat cultured hippocampal neurones. BMC Pharmacol (2007) 0.82
Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts. Behav Brain Res (2006) 0.82
Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe. ScientificWorldJournal (2009) 0.81
Store-operated Ca2+ entry in hippocampal neurons: Regulation by protein tyrosine phosphatase PTP1B. Cell Calcium (2012) 0.81
Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models. Behav Pharmacol (2015) 0.81
Long-term study of chronic oral aluminum exposure and spatial working memory in rats. Behav Neurosci (2002) 0.80
Sleep and hippocampus: do we search for the right things? Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.80
Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats. Psychopharmacology (Berl) (2002) 0.80
Regional cerebral blood flow and aberrant motor behaviour in Alzheimer's disease. Behav Brain Res (2011) 0.79
Impaired hippocampus-dependent spatial flexibility and sociability represent autism-like phenotypes in GluK2 mice. Hippocampus (2014) 0.79
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats. Sleep Disord (2012) 0.78
No spatial working memory deficit in beta-amyloid-exposed rats. A longitudinal study. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.78
FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease. Biochem Soc Trans (2011) 0.78
Visual acuity in the water maze: sensitivity to muscarinic receptor blockade in rats and mice. Behav Brain Res (2004) 0.78
Age-dependent changes in hippocampal synaptic transmission and plasticity in the PLB1Triple Alzheimer mouse. Cell Mol Life Sci (2013) 0.77
Cytoskeletal transport in the aging brain: focus on the cholinergic system. Rev Neurosci (2006) 0.77
Long-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice. Behav Brain Res (2013) 0.77
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol. Behav Pharmacol (2015) 0.77
Culturing conditions determine neuronal and glial excitability. J Neurosci Methods (2010) 0.77
Intracellular Ca2+ stores modulate SOCCs and NMDA receptors via tyrosine kinases in rat hippocampal neurons. Cell Calcium (2009) 0.76
Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459. Behav Pharmacol (2015) 0.76
Bi-directional alterations of LTP after acute homocysteine exposure. Behav Brain Res (2009) 0.76
What is the molecular pathology that underlies hippocampal memory decline? J Neurol Neurosurg Psychiatry (2009) 0.75
18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease. Chem Commun (Camb) (2013) 0.75
Parvalbumin-containing GABA cells and schizophrenia: experimental model based on targeted gene delivery through adeno-associated viruses. Behav Pharmacol (2017) 0.75
Stripline resonator and preamplifier for preclinical magnetic resonance imaging at 4.7 T. MAGMA (2011) 0.75